Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC
1:13-cv-03372
Overview
Parties
Defendant
Plaintiff
Purdue Pharmaceuticals, LLC NPE (University / Research)
Represented By
3 Attorneys ListedRopes & Gray, LLP (NYC)
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP (CA)
1900 University Avenue, 6th Floor
Counter Defendant
The P.F. Laboratories, Inc. Operating Company
Represented By
3 Attorneys ListedRopes & Gray, LLP (NYC)
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP (CA)
1900 University Avenue, 6th Floor
Purdue Pharma L.P. NPE (University / Research)
Represented By
3 Attorneys ListedRopes & Gray, LLP (NYC)
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP
1211 Avenue of the Americas, New York, NY 10036
Ropes & Gray, LLP (CA)
1900 University Avenue, 6th Floor
Court & Judges
Court
District Court, S.D. New York (nysd)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 22 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8114383
Abuse-proofed dosage form
|
Filed: 2003-11-20
Issued: 2012-02-14
|
Expired (Term Ended)
+325d PTA
Expires: 2024-10-10
|
|
|
US8337888
Pharmaceutical formulation containing gelling agent
|
Filed: 2012-01-12
Issued: 2012-12-25
|
Active (5.1 yrs remaining)
Expires: 2032-01-12
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
High PTA (+325 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
10
Dispositive
0
Granted
0
Denied
1
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings